1American Diabetes Association. Screening for type 2 diabetes[J]. Diabetes Care,2000,23(suppl 1):s20-s23.
2Grundy S M, Benjamin I J, Burke G L, et a1. Diabetes and cardiovascular disease. A statement for health care professionals from the American Heart Association[J]. Circulation, 1999,100:1134-1136.
3McGiIl H C, McMaban A, Malcolm G T, et al. Relation of glycohemoglobin and adiposity in youth [J].Arterioscler Thromb Vasc Biol, 1999,15:431-440.
4Turner R C, Millns H, Neil H A W, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23)[J]. BMJ,1998,318:823-828.
5Stratton I M, Adler A I, Neil H A. Association of glycaemia with macrovascular and microvascular complication of type 2 diabetes (UKPDS:35): prospective observational study[J]. BMJ, 2000, 321:405-412.
6Anderson D K A,Svardsudd K.Long-term glycemic control relates to mortality in type II diabetes[J]. Diabetes Care, 1995,18:1534-1543.
7Abu-lebden H S,Hodge D O,Nguyen T T,et al. Predictors of macrovascular disease in patients with type2 diabetes mellitus [J].Mayo Clin Proc,2001,76:707-712.
8Tominaga M, Eguchi H,Manaka H,et al. Impaired glucose tolerance is a risk factor for cardiovascular disease,but not impaired fasting glucose[J]. Diabetes Care, 1999,22:920-924.
9Asakawa H, Tokunaga K, Kawakami F. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease,and coronary heart disease in Japanses type 2 diabetes mellitus patients[J]. J Diabetes Comp,2000,14:307-313.
10Bonora E, Willeit J, Kiechl S, et al. Shaped and Jshaped relationships between serum insulin and coronary heart disease in the general population: the Bruneck Study[J]. Diabetes Care, 1998,21:221-230.
6Almdal T, Scharling H, Jensen JS, et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke,and death. A population based study of 13 000 men and women with 20 years of follow-up. Arch Intern Med, 2004,164 : 1422-1426.
7Hoogeveen RC,Ballantyne CM,Bang H,et al. Circulating oxi dized low-density lipoprotein and intercellular adhesion mole cule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia, 2007,50 : 36 -42.
8Rowley KG,Danielt M, O'Deat K. Screening for diabetes in indigenous populations using glycated haemoglobin: sensitivi ty, specificity, post test likelihood and risk of disease. Diabetes Med,2005,22 :833- 839.
9Peppa M, Uriberri J, Vlassara H. The role of advanced glyca tion end products in the development of atherosclerosis. Curt Diab Rep,2004,4:31-36.
